Chicago Rivet & Machine (CVR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
29 Sep, 2025Executive summary
Net sales for Q3 2024 were $6.97M, down 12.3% year-over-year, with a net loss of $1.45M versus a $964K loss in Q3 2023.
Nine-month net sales were $22.88M, down 7.5% year-over-year, with a net loss of $2.0M, improved from a $2.86M loss in the prior year.
Fastener segment sales declined sharply, especially in automotive, while assembly equipment sales and margins improved.
Gross margins improved in both segments due to price increases, cost reductions, and efficiency gains.
Financial highlights
Q3 2024 net sales: $6.97M (down 12.3% YoY); nine-month net sales: $22.88M (down 7.5% YoY).
Q3 2024 net loss: $1.45M ($1.50/share); nine-month net loss: $2.0M ($2.07/share).
Q3 gross profit: $694.99K; nine-month gross profit: $2.85M.
Cash, cash equivalents, and short-term investments at $2.16M as of September 30, 2024.
Working capital at $12.84M, down from $13.98M at year-end.
Outlook and guidance
Automotive fastener volumes are expected to remain weak for the rest of 2024, but cost structure and efficiency improvements are expected to benefit results when volumes recover.
Non-automotive fastener and assembly equipment segments are seen as growth opportunities.
Latest events from Chicago Rivet & Machine
- Net loss widened and liquidity concerns persist, raising substantial doubt about going concern.CVR
Q2 2026 - Sales and margins declined sharply in Q1 2026, raising substantial going concern risks.CVR
Q1 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.CVR
Proxy filing - Substantial doubt remains about going concern status despite improved margins and narrowed losses.CVR
Q4 2025 - Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 2024 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 2024 - Gross margin and net income improved despite lower sales, but liquidity risks persist.CVR
Q1 2025